Skip to content

Novavax NVAX Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin85%-8.5pp93.5%+1.7pp91.8%+3.5pp88.3%+0.8pp87.4%+17.2pp
Operating margin-13.1%-53.4pp40.3%+11.4pp28.9%-3.7pp32.6%-0.2pp32.8%+69.3pp
Net margin-14.7%-53.9pp39.2%+7.1pp32.1%-7.1pp39.2%+1.1pp38.1%+65.6pp
EBITDA margin-9.4%-52.1pp42.8%+10.6pp32.2%-4.2pp36.4%+0.1pp36.3%+65.7pp
Returns
Return on assets-7.5%-39.7pp32.2%+8.5pp23.6%-3.2pp26.8%-9.4pp36.2%+47.3pp
Efficiency
Asset turnover0.5×-0.3×0.8×+0.1×0.7×+0.1×0.7×-0.3×0.9×+0.5×
Inventory turnover8.3×+1.1×7.2×-0.7×7.9×-5.1×13.1×+0.9×12.1×+4.1×
Liquidity
Current ratio2.5×+0.4×2.1×-0.1×2.3×-0.1×2.4×+0.3×2.1×+1.1×
Quick ratio2.5×+0.3×2.1×-0.1×2.2×-0.1×2.3×+0.3×+1.1×
Cash ratio0.7×+0.1×0.5×-0.1×0.6×0.0×0.7×0.0×0.6×+0.2×
Leverage
Debt-to-assets0.3×0.0×0.2×+0.2×0.0×0.0×0.0×
Interest coverage-3.6×-23.7×20.1×+7.4×12.6×-2.6×15.2×-3.7×19×+31.4×
Per Share
Book value per share-$0.89-20.1%-$0.74+23.5%-$0.97-555%$0.21+150%-$0.43+89.6%
Valuation
Market capitalization$1.41B+35.6%$1.09B-22.5%$1.41B+34.0%$1.05B+2.0%$1.03B-19.9%
Enterprise value$1.47B+76.9%$1.13B-1.4%$1.15B+34.2%$855.37M+3.5%$826.21M-3.8%
Price / sales2.4×+1.5×-0.4×1.3×+0.3×+0.2×0.8×-1.1×
EV / sales2.5×+1.8×-0.1×1.1×+0.3×0.8×+0.1×0.7×-0.6×
Earnings yield-6.2%-52.3pp40.3%+16.1pp24.3%-16.0pp40.2%-6.2pp46.4%+61.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Novavax's profit margins?
Novavax (NVAX) runs a 85.0% gross margin and a -13.1% operating margin, with a -14.7% net margin.
Where do Novavax's ratios come from?
Every ratio is computed from Novavax's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.